High risk, narrow markets stunting growth for MDx March 7, 2011 By John Brosky VIENNA – The bubble of hype surrounding molecular diagnostics (MDx) has burst, leaving Fabian Kiessling, MD, a lone voice still preaching its promise at this radiology congress. (Medical Device Daily)Read More